Background-Welders are at increased risk of pneumococcal pneumonia. The mechanism for this association is not known. The capacity of pneumococci to adhere to and infect lower airway cells is mediated by host-expressed platelet-activating factor receptor (PAFR).
pneumococcal adhesion and infection in human lower airway cells in vitro, and PAFRdependent pneumococcal airway infection in a mouse model. We also assessed PAFR in stored lung tissue from a study in which mice were exposed to aerosolized stainless steel welding fumes (StS-WF) and from a study of particles in welders' lungs. 16 
METHODS

WF: Generation and composition
MS-WF were a gift from the Welding Institute (Cambridge, UK). MS-WF were obtained by using a standardized method in accordance with the International Standard 15011-1:2009, as previously described. 17 Briefly, manual metal arc welding electrodes (mild steel E7018 basic type) were run to produce a weld bead inside a fume collection system. MS-WF with a mode particle diameter of 6.8 µm 18 were extracted through the hood on top of the box, collected on a filter paper, removed by brushing, and stored in airtight glass containers. The composition of MS-WF was determined after digestion in nitric/hydrochloric acid in a hightemperature, closed-vessel, microwave-assisted dissolution system. Analysis was done by using inductively coupled plasma-atomic emission spectroscopy. Before use, MS-WF were suspended in PBS.
WF: OP
The OP of MS-WF was determined based on their ability to oxidize antioxidants from a validated in vitro respiratory tract lining fluid model containing equimolar (200 µmol/L) and physiologically relevant concentrations of ascorbate, urate, and glutathione. 19 Incubations were performed with particle suspensions at a final concentration of 50 µg/mL for 4 hours at 37°C (pH 7.4) in parallel to particle-free and PM controls (an oxidatively inert carbon black [M120] and an oxidatively active urban PM [NIST1648a]). At the end of this period, particles were removed by means of centrifugation (13,000 rpm at 4°C), and samples were acidified with metaphosphoric acid (final concentration 5%) before determination of the remaining antioxidant concentrations by using reverse-phase HPLC with electrochemical detection (for ascorbate) and the glutathione disulphide-reductase-5, 5′-dithio-bis (2-nitrobenzoic acid) recycling assay (for glutathione). 19 OP was determined based on the percentage loss of ascorbate and glutathione over the 4-hour incubation period relative to a 4-hour particle-free control (reflecting background auto-oxidation rates). Under these conditions, urate losses are not significant. 16, 17 The percentage loss of ascorbate and glutathione over the 4-hour incubation was then normalized to the particle concentration used in the respiratory tract lining fluid assay (50 µg/mL) to generate 2 separate measures of OP: glutathione-dependent OP (OP glutathione ) per microgram and ascorbate-dependent OP (OP ascorbate ) per microgram. In addition, an aggregate sum of the 2 measures was calculated (OP total per microgram), 20 previous work having shown that ascorbate and glutathione oxidation is sensitive to different panels of oxidants. 16, 17 Pneumococcal adhesion and infection: Human airway cells A549 cells, a type II pneumocyte cell line (Sigma-Aldrich, Poole, UK),were maintained in Dulbecco modified Eagle medium supplemented with FBS, L-glutamine, and antibiotics (Lonza, Basel, Switzerland). Passage number was less than 20. BEAS-2B, a bronchial epithelial cell line, was a gift from Dr Nicolas Mercardo (National Heart and Lung Institute, Imperial College London, London, UK). BEAS-2B cells were maintained in RPMI-1640 medium containing HEPES (Life Technologies, Warrington, UK) supplemented with FBS L-glutamine and antibiotics. Passage number was less than 20.
Cell viability was assessed by using the lactate dehydrogenase (LDH) assay (SigmaAldrich), according to the manufacturer's instructions. Cells treated with distilled water (indicating 100% LDH release) were used as a positive control. Primary human bronchial epithelial cells (purchased from Promocell, Heidelberg, Germany; lot no. 4032402) were maintained according to the manufacturer's instructions. Passage number was less than 4. The type 2 S pneumoniae encapsulated strain D39 was purchased from the National Collection of Type Cultures (NCTC 7466; Central Public Health Laboratory, London, UK) and grown in liquid culture brain-heart infusion broth (Oxoid, Basingstoke, UK) to the midlogarithmic phase (OD 600 =0.4-0.6) before use.
Pneumococcal adhesion and infection, and infection alone of airway cells were assessed by using a standard in vitro assay. 14, 15 Briefly, airway epithelial cells were cultured with MS-WF for 2 hours, washed, and infected with S pneumoniae at a multiplicity of infection of 100 for 2 hours to assess the combination of pneumococcal adhesion and infection of cells. Cells were then vigorously washed, detached, and lysed with sterile distilled water. Serial dilutions of the samples were plated on brain-heart infusion agar containing 5% horse blood (Oxoid), and colony-forming units (CFU) per milliliter were assessed. In this assay CFU values after cell lysis reflect both pneumococci attached to the surfaces of airway cells (ie, the adherent fraction) and pneumococci that penetrate into cells (ie, the infective fraction). The adherent fraction was first killed with gentamicin (200 mg/mL) and penicillin G (10 mg/mL), to assess the infective fraction alone. Intracellular pneumococci that were protected from antibiotics were recovered by means of cell lysis with ice-cold sterile water, and CFU values were determined. 15 The functional role of PAFR was assessed by adding a specific PAFR blocker, (RS)-2-methoxy-3-(octadecylcarbamoyloxy)-propyl2-(3-thiazolio) ethylphosphate (CV-3988), 21 at a final concentration of 20 µmol/L. The role of oxidative stress was assessed by adding the thiol antioxidant N-acetylcysteine (NAC; SigmaAldrich) 22 at a final concentration of 5 mmol/L at the same time as MS-WF.
Pneumococcal infection: Mouse model
Four-to 6-week-old female CD1 mice (Charles River, Welwyn Garden City, UK) were exposed to MS-WF in 50 µL of PBS (administered either as a single 600-µg dose or as divided doses) through intranasal installation after achievement of isoflurane anesthesia. Twenty-four hours after instillation of MS-WF, animals were intranasally infected with 5 × 10 6 S pneumoniae strain D39 in 50µL of PBS. Animals were killed at 24 hours after pneumococcal infection by using a pentobarbital overdose. Pneumococcal CFU values in bronchoalveolar lavage fluid (BALF), lung tissue (done after BAL), and blood were assessed by plating serial dilutions on brain-heart infusion agar containing 5% horse blood (Oxoid). Mouse experiments were approved by University College London's Biological Services Ethical Committee under UK Home Office Project License PPL70/6510 and performed according to UK national guidelines for animal use and care under UK Home Office license in accordance with European Union Directive 2010/63/EU. Animals received 30 µL of 5 mg/kg of the PAFR blocker CV-3988 (Sigma-Aldrich) administered by means of tail vein injection 1 hour before pneumococcal infection to assess the effect of blocking PAFR.
PAFR expression: Human airway cells
Expression of PAFR protein by airway cells in vitro was quantified by means of florescence microscopy. Briefly, 4 × 10 5 cells were grown on cover-slips in 24-well plates and cultured with MS-WF. Cells were fixed in ice-cold 4% paraformaldehyde for 10 minutes at room temperature and washed with PBS with 10% FCS (wash buffer). Cells were exposed overnight at 4°C to either a mouse anti-human PAFR IgG 2a antibody (1:100, CAY160600; Cayman Chemicals, Ann Arbor, Mich) or a mouse IgG isotype control (Bio-Legend, San Diego, Calif). Cells were washed with wash buffer and an Alexa Fluor 488-conjugated goat anti-mouse antibody applied (1:1000; Invitrogen, Grand Island, NY) at room temperature for 30 minutes under aluminum foil. Cells were washed with wash buffer and 4′, 6-Diamidino-2-Phenylindole, Dilactate (1:1000, Invitrogen) applied at room temperature for 15 minutes under aluminum foil. Finally, cells were washed with wash buffer, and the coverslips were mounted on glass slides and sealed. Slides were left to air dry under foil for 4 hours and stored overnight at 4°C for analysis. Images were taken with an epifluorescence microscope and analyzed by using ImageJ software (National Institutes of Health, Bethesda, Md). The isotype control confirmed that interactions between the anti-human PAFR antibody and the secondary antibody detected by using immunofluorescence microscopy were specific. Images were obtained from 3 randomly selected areas of each slide and analyzed blind to exposure status. By using the software, a florescence intensity threshold was set to discount background nonspecific florescence. The area of specific florescence was then measured for each image, with 1 to 3 images analyzed in each experiment and expressed as square micrometers.
PAFR mRNA expression: Mouse model
Expression of mouse lung PAFR mRNA was assessed by means of quantitative PCR. Briefly, lungs were removed and stored in RNAlater (Qiagen, Manchester, UK) at −80°C. RNA was extracted with the RNeasy Kit (Qiagen). First-strand cDNA synthesis was carried out with SuperScript VILO MasterMix (Life Technologies). Real-time PCR was carried out with TaqMan Gene Expression MasterMix (Life Technologies). mRNA analysis was carried out according to the manufacturer's instructions by using relative quantification involving normalization to a reference gene. Primer/ probe sets used were as follows: mouse reference gene β 2 -microglobulin, Mm00437762_m1; mouse PAFR, Mm02621061_m1 (Life Technologies). All primer/probe sets spanned exon-exon boundaries to control for genomic DNA contamination.
by means of whole-body inhalation to 40 mg/m 3 StS-WF for 3 hours per day for up to 10 days. Lung PAFR mRNA expression was compared between air-exposed and StS-WFexposed controls at both 4 hours and 28 days after the last dose. The design and construction of the aerosol generator and the characterization of StS-WF have been previously described. 23 Full details are provided in the Methods section in this article's Online Repository at www.jacionline.org.
The distribution of airway PAFR in a nonsmoking welder and a nonsmoking non-WFexposed control subject was assessed by immunostaining samples from a study in which normal tissue was obtained at the time of a clinical biopsy for suspected cancer. 16 Full details are provided in the Methods section in this article's Online Repository. Previous sampling and present analysis of human lung tissue was approved by an institutional review board for human studies. 16 
Statistical analysis
Statistical analysis was done with GraphPad Prism software (version 5.03; GraphPad Software, La Jolla, Calif). Data were obtained from at least 3 separate experiments performed at different times, with each data point representing the mean of at least 3 replicates, unless otherwise stated. Data from in vitro airway epithelial experiments were analyzed by using either the t test or 1-wayANOVAand the Tukey multiple comparison test and are summarized as means (SEMs). Data from animal experiments are summarized by medians and analyzed either by using the Mann-Whitney test or Kruskal-Wallis test and the Dunn multiple comparison test. A P value of less than .05 was considered significant.
RESULTS
WF: OP
MS-WF contained iron, manganese, titanium, aluminum, and zinc (Table I ). The OP of MW-WF for ascorbate and glutathione was increased compared with that of carbon black, and the total OP of MS-WF was increased compared with that of urban PM (Fig 1) .
Pneumococcal adhesion and infection: Human airway cells
We first performed dose-response experiments with A549 and BEAS-2B cells to determine the optimal concentration of MS-WF that stimulated adhesion without causing cytotoxicity. MS-WF at concentrations between 200 and 400 µg/mL for 2 hours increased pneumococcal adhesion and infection of both airway cell lines (Fig 2) without causing cytotoxicity, as assessed based on LDH release (see Fig E1 in this article' s Online Repository at www.jacionline.org). A lower concentration of MS-WF (10 µg/mL) stimulated pneumococcal adhesion and infection, but this required extending culture duration to 24 hours (see Fig E2 in this article' s Online Repository at www.jacionline.org). Thus we chose to expose cells to MS-WF for 2 hours at 275 µg/mL (145 µg/cm 2 ) for A549 cells and 200 µg/mL (105 µg/cm 2 ) for BEAS-2B cells. By adding antibiotics to kill the fraction of pneumococci adherent to cell surfaces, it was determined that MS-WF for 2 hours also increased the infective pneumococcal growth (data not shown).
Pneumococcal infection: Mouse model
Intranasal instillation of a single 600-µg dose of MS-WF in mice 24 hours before pneumococcal infection resulted in an increase in BALF and lung pneumococcal CFU values at 24 hours after pneumococcal infection (Fig 4) . BALF and lung pneumococcal CFU values were also increased when MS-WF was administered as 6 separate 100-µg doses once a day for 6 days (total, 600 µg), followed by infection 24 hours after the last dose (see Fig  E3 in this article' s Online Repository at www.jacionline.org). In this model pneumococci were not isolated from the blood.
PAFR-dependent adhesion and infection: Human airway cells
A549 and BEAS-2B cell culture with MS-WF for 2 hours increased PAFR protein expression (Fig 5) . The addition of CV-3988 to MS-WF-exposed cells reduced pneumococcal adhesion and infection of A549 and BEAS-2B cells and of human primary bronchial epithelial cells (Fig 6) . Adding NAC at the same time as MS-WF attenuated pneumococcal adhesion and infection of A549 and BEAS-2B cells (Fig 7) .
PAFR-dependent infection: Mouse model
A single intranasal dose of 600 µg of MS-WF increased lung PAFR mRNA expression at 24 hours (Fig 8) . Pretreatment of MS-WF-exposed mice with CV-3988 1 hour before infection attenuated BALF CFU values. Pretreatment of MS-WF-exposed mice with CV-3988 did not reduce lung CFU values (Fig 9) . In PBS-treated animals CV-3988 had no effect on either BALF or lung CFU values (data not shown).
PAFR: Stored samples
A 10-day course of 40 mg/m 3 of aerosolized StS-WF for 3 hours per day increased mouse lung PAFR mRNA expression compared with that seen in air-exposed control subjects at both 4 hours and 28 days after the last dose (see Fig E4 in this article' s Online Repository at www.jacionline.org).
Lung biopsy tissue was available from a single nonsmoking welder and a single nonsmoking control subject. Specific PAFR immunostaining of bronchial and alveolar epithelial cells was present in the nonsmoking welder. Less intense specific bronchial epithelial PAFR was present in the nonsmoking control subject (see Fig E5 in this article' s Online Repository at www.jacionline.org).
DISCUSSION
In this study we sought to identify a mechanism for the hypersusceptibility of welders to bacterial pneumonia reported in epidemiologic studies. 2, 4, 24 We focused on S pneumoniae because this bacterium is the most common cause of community-acquired pneumonia in adults. 10 In addition, a review of all patients presenting with invasive pneumococcal disease (IPD) in Alberta (Canada) from 2000 to 2004 by Wong et al 25 reported a 2.7-fold greater incidence of IPD in welders; of the 18 welders with IPD, 17 had bacteremic pneumococcal pneumonia, 1 had meningitis, and 1 died of pneumococcal infection. Pneumococcal infection in welders remains a problem. For example, in April 2015, the Northern Ireland Health Protection Service investigated an outbreak of IPD in shipyard workers and identified WF exposure as a possible risk factor. 26 In the present study we found that intranasal instillation of MS-WF in mice, followed by infection with S pneumoniae, resulted in a 50-to 175-fold increase in airway and lung CFU values.
We also found that MS-WF-induced hypersusceptibility to pneumococcal infection is mediated in part by PAFR (a host receptor used by pneumococci to adhere to and infect lower airway cells 13 ) because MS-WF increased mouse lung PAFR mRNA expression and that treatment of mice with the PAFR blocker CV-3988 before pneumococcal infection significantly reduced lower airway bacterial load. Additional evidence for a role of PAFR was provided by in vitro experiments. First, MS-WF stimulated PAFR-dependent adhesion and infection of human lower airway cells. Second, CV-3988 attenuated MS-WF-stimulated pneumococcal adhesion and infection of human airway cell line cells and primary bronchial epithelial cells. Pneumococcal adhesion and infection stimulated by MS-WF is likely to be mediated by cellular oxidative stress because this is blocked by the antioxidant NAC. Indeed, these data are compatible with previous reports of induction of cellular oxidative stress by WF 27 and the capacity of NAC to attenuate pneumococcal adhesion and infection stimulated by fossil-fuel PM. 14 Furthermore, increased glutathione peroxidase and total antioxidants in the serum of active welders provides evidence that WF induce oxidative stress in vivo. 28 To date, the role of PAFR in mediating vulnerability to pneumococcal pneumonia in human subjects is not fully defined. 29 However, this role is well established in animal models. For example, reduced PAFR expression by lower airway epithelial cells decreases mortality from pneumococcal infection in mice. 30 Conversely, increased airway epithelial PAFR causes hypersusceptibility of mice to pneumococcal infection. 31 Indirect evidence that airway PAFR is important in human subjects is provided by our previous observation that bronchial epithelial PAFR expression is increased in smokers. 15 In the present study PAFR was more strongly expressed by lower airway epithelial cell counts in the nonsmoking welder compared with the nonsmoking, non-WF-exposed control subject. To determine whether epithelial PAFR expression is increased in welders requires further lung biopsy samples from nonsmoking welders and nonsmoking control subjects, but to date, these have not been obtained.
The limitations of this study are as follows. First, it is unclear whether the concentrations of MS-WF used in vitro reflect exposure of airway cells in vivo. However, concentrations of MS-WF used in the adhesion and infection assays are similar to those estimated by Phalen et al 32 (85 µg/cm 2 ) for hot spots of inhaled PM deposition on airway cells. Furthermore, we found that lower concentrations of MS-WF (ie, 5 µg/cm 2 ) stimulated pneumococcal adhesion and infection but required prolonged culture duration.
Second, it is unclear whether a single 600 µg intranasal dose of MS-WF in the mouse reflects the dose inhaled by welders. However, there is evidence that welders inhale very high concentrations of PM. For example, Kim et al 33 reported mean daily exposures of welders to inhalable PM of 1660 µg/m 3 compared with 40 µg/m 3 in nonexposed control subjects.
Third, we did not assess the effect of aerosolized MS-WF, amore physiologic delivery method. However, using stored samples, we found that exposure of mice to aerosolized StS-WF stimulates lung PAFR mRNA expression. Furthermore, our pilot data suggest that StS-WF also stimulates PAFR-dependent pneumococcal adhesion and infection to lower airway cells in vitro (see Fig E6 in this article' s Online Repository at www.jacionline.org). Finally, it is unclear why pretreatment of MS-WF-exposed mice with the PAFR blocker CV-3988 attenuates airway (BALF) CFU values but does not attenuate lung tissue CFU values. We speculate that although PAFR-dependent adhesion is important in establishing airway infection, PAFR-independent mechanisms contribute to the development of pneumococcal infection in the lung tissue compartment.
In summary, we found that MS-WF increases PAFR-dependent pneumococcal adhesion and infection of human lower airway cells in vitro and pneumococcal airway infection in mice. This study suggests a mechanism for the increased vulnerability of welders to pneumococcal pneumonia reported in epidemiologic studies. Therefore these data provide biological plausibility for the UK Health and Safety Executive Guideline that the 23-valent pneumococcal polysaccharide vaccine "should be considered for people whose work exposes them to frequent or continuous exposure to metal fume (e.g. welders), taking into account the exposure control measures in place." 34 
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Effect of exposure of human airway cells in vitro to MS-WF for 2 hours on the infective fraction of S pneumoniae. Cells were infected with S pneumoniae for 2 hours at a multiplicity of infection of 100. Pneumococci that were adherent to cell surfaces were first killed by antibiotics to assess the infective fraction. Intracellular bacteria that were protected from antibiotics were then recovered by means of cell lysis, and CFU values were assessed by means of quantitative culture. A, A549 cells cultured with 275 µg/mL (145 µg/cm 2 ). B, BEAS-2B cells cultured with 200 µg/mL (105 µg/ cm 2 ). Data are from 3 separate experiments, with 3 technical replicates per experiment, and presented as means (SEMs). Data are compared by using t tests. *P < .05. Each element is represented as a percentage of the total weight of the sample provided. The composition of MS-WF was determined by using inductively coupled plasma-atomic emission spectroscopy.
